Farah R. W. Kools

CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth

P. Reeves, M. Poznansky, Mojgan A. Abbaslou, 2017, Anti-cancer drugs.

Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

R. Schinazi, P. Reeves, K. Vutipongsatorn, 2017, Oncotarget.

Lysyl oxidase‐like 2 is a regulator of angiogenesis through modulation of endothelial‐to‐mesenchymal transition

B. W. van Balkom, M. Verhaar, Olivier G. de Jong, 2018, Journal of cellular physiology.

Publications Are Not the Finish Line: Focusing on Societal Rather Than Publication Impact

M. Grandner, S. Mirali, G. Cavalli, 2018, Front. Med..

One size does not fit all: an exploratory interview study on how translational researchers navigate the current academic reward system

H. V. van Rijen, B. Prakken, Farah R. W. Kools, 2023, Frontiers in Medicine.